89bio, Inc.
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibrob…
Government Awards Analysis Beta
It's important to keep an eye on government contracts, because they can make up a substantial portion
of total sales for your researched company.
The Data for the government spending analysis is directly sourced from the
US gov. application interface.
Obligations Over-Time
89bio, Inc. has no obligation with a government/award agency.
Latest Obligations
Spending By Type
89bio, Inc. can't present spending by time.
Get PRO Today
With PRO you will unlock all insights related to government awards of 89bio, Inc..